All Stories

  1. Is there a role for antibodies targeting muscarinic acetylcholine receptors in the pathogenesis of schizophrenia?
  2. Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies
  3. Characterization of genetic variants in the NFKBIA promoter region in multiple sclerosis
  4. Thiopalmitoylated altered peptide ligands can successfully treat established disease in an animal model of multiple sclerosis
  5. PLP1 mutations in patients with multiple sclerosis: Identification of a new mutation and analysis of in vitro effects of PLP1 mutations
  6. Quantitative Proteome Profiling of CNS-Infiltrating Autoreactive CD4 + Cells Reveals Selective Changes during Experimental Autoimmune Encephalomyelitis
  7. Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia
  8. Increased expression of the hypoxia-related genes in peripheral blood leukocytes of human subjects with acute ischemic stroke
  9. Thiopalmitoylation of Altered Peptide Ligands Enhances Their Protective Effects in an Animal Model of Multiple Sclerosis
  10. Sexual Dimorphism in the Immune System
  11. Correlation of Adrenomedullin gene expression in peripheral blood leukocytes with severity of ischemic stroke
  12. Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple Sclerosis
  13. Gene Expression in the Spinal Cord in Female Lewis Rats with Experimental Autoimmune Encephalomyelitis Induced with Myelin Basic Protein
  14. Interleukin-6 Gene Promoter-572 C Allele May Play a Role in Rate of Disease Progression in Multiple Sclerosis
  15. The role of epigenetic mechanisms and processes in autoimmune disorders
  16. Closing the case ofAPOEin multiple sclerosis: no association with disease risk in over 29 000 subjects: Figure 1
  17. Female reproductive issues in multiple sclerosis
  18. Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability
  19. Frequency and function of regulatory T cells after ischaemic stroke in humans
  20. Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms
  21. Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke
  22. Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips
  23. Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data
  24. Investigation of the [−/A]8and C1236T genetic variations within the human toll-like receptor 3 gene for association with multiple sclerosis
  25. Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies
  26. The effect of aging on human lymphocyte subsets: comparison of males and females
  27. Sexual Dimorphism in Autoimmune Disease
  28. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis
  29. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
  30. Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis
  31. Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population
  32. CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia
  33. An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population
  34. Immune activation in the peripheral blood of patients with acute ischemic stroke
  35. Myelin proteolipid protein: An effective autoantigen and target of autoimmunity in multiple sclerosis
  36. Correlation of Blood T Cell and Antibody Reactivity to Myelin Proteins with HLA Type and Lesion Localization in Multiple Sclerosis
  37. Route of Uptake of Palmitoylated Encephalitogenic Peptides of Myelin Proteolipid Protein by Antigen-Presenting Cells: Importance of the Type of Bond between Lipid Chain and Peptide and Relevance to Autoimmunity
  38. Immunology of multiple sclerosis
  39. Studies of HLA associations in male and female patients with Guillain–Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
  40. INFLAMMATORY DISORDERS OF THE NERVOUS SYSTEM: PATHOGENESIS, IMMUNOLOGY, AND CLINICAL MANAGEMENT
  41. Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndrome
  42. The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DR 1 chain is associated with the clinical course of multiple sclerosis
  43. Blood–brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement
  44. Immune dysregulation and self‐reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?
  45. Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis
  46. Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls
  47. Solid-phase synthesis of a biotin-labelled thiopalmitoylated myelin proteolipid protein epitope and application in the study of uptake of antigen by macrophages
  48. Solid-phase synthesis of a biotin-labelled thiopalmitoylated myelin proteolipid protein epitope and application in the study of uptake of antigen by macrophages
  49. Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents
  50. Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis
  51. Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization
  52. Myelin proteolipid protein—the first 50 years
  53. Thiopalmitoylation of Myelin Proteolipid Protein Epitopes Enhances Immunogenicity and Encephalitogenicity
  54. Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151
  55. Surges of Increased T Cell Reactivity to an Encephalitogenic Region of Myelin Proteolipid Protein Occur More Often in Patients with Multiple Sclerosis Than in Healthy Subjects
  56. A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction
  57. Reply
  58. Reply
  59. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis
  60. Autopathogenic T Helper Cell Type 1 (Th1) and Protective Th2 Clones Differ in Their Recognition of the Autoantigenic Peptide of Myelin Proteolipid Protein
  61. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis
  62. Orientation of myelin proteolipid protein in the oligodendrocyte cell membrane
  63. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
  64. Chapter 29 Expression of myelin proteolipid protein in oligodendrocytes and transfected cells
  65. Autoantigenic PLP peptides identified by MHC binding
  66. Minireview: Autoimmune responses to myelin proteolipid protein
  67. Immunolocalization of proteolipid protein peptide 103-116 in myelin
  68. Effects of anti-idiotype vaccine on tumour growth and on production of soluble factors modulating cell-mediated immunity in vitro
  69. Comparison of T suppressor factors from tumour-bearing mice and mice immunized with a monoclonal anti-idiotypic antibody
  70. Auto-anti-idiotypic antibodies in mice hyperimmunized with a chemically induced bladder carcinoma